There are a number of errors in the “aOR (95%CI)” columns for Tables 3 and 4. During secondary analysis, the authors observed 128 duplicate entries in the study database among 4054 included in the analyses. Despite observing the random distribution of duplicates, the authors performed all analyses again after removal of the 128 duplicates (leaving 3926 patients in the analyses) and found negligible effect on the outcome measures: aOR for arm associated with unfavourable outcome now 0.93 (0.80–1.09) compared to 0.93 (0.79–1.08) in the original article; while aOR for TB-attributed deaths is 0.69 (0.46–1.04) compared to 0.65 (0.44–0.97). Even though the 95% confidence interval of the aOR for TB attributed death now includes 1, the difference with the originally reported aOR and the width of its confidence interval are minimal, hence the conclusions from the results remain unchanged. Please see the correct Tables 3 and 4 here.
Table 3. Characteristics associated with unfavourable outcomes in a multilevel logistic regression model.
| Characteristics | Unfavourable† (n = 1181) | Successful (n = 2745) | crude OR (95%CI) | aOR (95%CI) |
|---|---|---|---|---|
| Sex | ||||
| Male | 846 (33.2%) | 1700 (66.8%) | 1.5 (1.3–1.8) | 1.5 (1.3–1.8) |
| Female | 335 (24.3%) | 1045 (75.7%) | 1 (reference) | 1 (reference) |
| Age group (years) | ||||
| 0–14 | 18 (19.8%) | 73 (80.2%) | 0.76 (0.44–1.32) | 0.69 (0.39–1.3) |
| 15–29 | 704 (33.8%) | 1378 (66.2%) | 1.6 (1.3–2.0) | 1.6 (1.2–2.0) |
| 30–59 | 347 (26.9%) | 943 (73.1%) | 1.1 (0.90–1.5) | 1.1 (0.86–1.4) |
| ≥60 | 112 (24.2%) | 351 (75.8%) | 1 (reference) | 1 (reference) |
| HIV status | ||||
| Negative | 452 (21.2%) | 1675 (78.8%) | 1 (reference) | 1 (reference) |
| Positive | 171 (43.7%) | 220 (56.3%) | 2.9 (2.3–3.7) | 3.1 (2.4–3.9) |
| Unknown | 558 (39.6%) | 850 (60.4%) | 2.6 (2.2–3.0) | 2.6 (2.2–3.0) |
| City | ||||
| Manaus | 222 (28.5%) | 556 (71.5%) | 1 (reference) | 1 (reference) |
| Rio | 959 (30.5%) | 2189 (69.5%) | 1.1 (0.81–1.4) | 1.3 (1.01–1.7) |
| Type of diagnosis | ||||
| Confirmed* | 875 (30.9%) | 1960 (69.1%) | 1 (reference) | 1 (reference) |
| Clinically diagnosed, negative test§ | 198 (28.5%) | 496 (71.5%) | 0.89 (0.73–1.1) | 0.86 (0.71–1.04) |
| Clinically diagnosed, no test result | 108 (27.2%) | 289 (72.8%) | 0.82 (0.65–1.04) | 0.76 (0.59–0.97) |
| Arm | ||||
| Baseline | 556 (31.3%) | 1221 (68.7%) | 1 (reference) | 1 (reference) |
| Intervention | 625 (29.1%) | 1524 (70.9%) | 0.92 (0.79–1.06) | 0.93 (0.80–1.09) |
*Positive smear in baseline arm and positive Xpert in intervention arm.
§Negative smear in baseline arm and negative Xpert in intervention arm.
†Unfavourable = loss to follow up, death from any cause, transfer out and resistance.
Table 4. Characteristics associated with TB-attributed death in a multilevel logistic regression model.
| Characteristics | TB-attributed death (n = 119) | Successful (n = 2745) | crude OR (95%CI) | aOR (95%CI) |
|---|---|---|---|---|
| Sex | ||||
| Male | 83 (4.7%) | 1700 (95.3%) | 1.4 (0.95–2.1) | - |
| Female | 36 (3.3%) | 1045 (96.7%) | 1.0 (reference) | |
| Age group (years) | ||||
| 0–14 | 1 (1.3%) | 73 (98.7%) | 0.20 (0.03–1.6) | 0.14 (0.02–1.01) |
| 15–29 | 49 (3.4%) | 1378 (96.6%) | 0.54 (0.33–0.9) | 0.44 (0.26–0.76) |
| 30–59 | 46 (4.6%) | 943 (95.4%) | 0.74 (0.44–1.2) | 0.57 (0.33–0.98) |
| ≥60 | 23 (6.1%) | 351 (93.9%) | 1.0 (reference) | 1.0 (reference) |
| HIV status | ||||
| Negative | 25 (1.5%) | 1675 (98.5%) | 1.0 (reference) | 1.0 (reference) |
| Positive | 44 (16.7%) | 220 (83.3%) | 14.0 (8.1–24.2) | 16.1 (9.2–28.3) |
| Unknown | 50 (5.6%) | 850 (94.4%) | 4.1 (2.4–6.7) | 4.3 (2.6–7.1) |
| City | ||||
| Manaus | 21 (3.6%) | 556 (96.4%) | 1.2 (0.73–1.9) | 1.96 (1.01–3.8) |
| Rio | 98 (4.3%) | 2189 (95.7%) | 1.0 (reference) | 1.0 (reference) |
| Type of diagnosis | ||||
| Confirmed* | 81 (4.0%) | 1960 (96.0%) | 1.0 (reference) | |
| Clinically diagnosed, negative test§ | 25 (4.8%) | 496 (95.2%) | 1.2 (0.77–1.9) | - |
| Clinically diagnosed, no test result | 13 (4.3%) | 289 (95.7%) | 1.1 (0.59–2.0) | |
| Arm | ||||
| Baseline | 68 (5.3%) | 1221 (94.7%) | 1.0 (reference) | 1.0 (reference) |
| Intervention | 51 (3.2%) | 1524 (96.8%) | 0.60 (0.42–0.85) | 0.69 (0.46–1.04) |
OR = odds ratio, aOR = adjusted odds ratio
*Positive smear in baseline arm and positive Xpert in intervention arm
§ Negative smear in baseline arm and negative Xpert in intervention arm
Reference
- 1.Trajman A, Durovni B, Saraceni V, Menezes A, Cordeiro-Santos M, Cobelens F, et al. (2015) Impact on Patients’ Treatment Outcomes of XpertMTB/RIF Implementation for the Diagnosis of Tuberculosis: Follow-Up of a Stepped-Wedge Randomized Clinical Trial. PLoS ONE 10(4): e0123252 doi:10.1371/journal.pone.0123252 [DOI] [PMC free article] [PubMed] [Google Scholar]
